Corrigendum: Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy

Yurong Qin, Miaozhe Huo, Xingwu Liu*, Shuai Cheng Li*

*Corresponding author for this work

Research output: Journal Publications and ReviewsErratum

2 Citations (Scopus)

Abstract

A Corrigendum on
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy


By Qin Y, Huo M, Liu X and Li SC (2024). Front. Immunol. 15:1368749.
doi: 10.3389/fimmu.2024.1368749

In the published article, there was an error in the Funding statement. We only stated, “This research was funded by The Science Technology and Innovation Committee of Shenzhen Municipality (Project No. JCYJ20200109143216036),” and omitted “The National Natural Science Foundation of China (Grant No. 62072433)” funding information. The correct Funding statement appears below.

FUNDING

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was funded by The National Natural Science Foundation of China (Grant No. 62072433) and The Science Technology and Innovation Committee of Shenzhen Municipality (Project No. JCYJ20200109143216036).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. Copyright
© 2024 Qin, Huo, Liu and Li.
Original languageEnglish
Article number1438587
JournalFrontiers in Immunology
Volume15
Online published4 Jun 2024
DOIs
Publication statusPublished - 2024

Research Keywords

  • biomarkers
  • computational models
  • ICI immunotherapy
  • prediction of treatment effectiveness
  • tumor

Fingerprint

Dive into the research topics of 'Corrigendum: Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy'. Together they form a unique fingerprint.

Cite this